| Sav-on Pharmacy #0469 | |
| 12811 Beverly Park Rd, Lynnwood, Washington 98087 | |
| (425) 347-3145 |
| Name | Sav-on Pharmacy #0469 |
|---|---|
| Organization Name | Albertsons Llc |
| Location | 12811 Beverly Park Rd, Lynnwood, Washington 98087 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (425) 347-3145 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.
The Office of the Inspector General of the Department of Health and Human Services released a "Review of the Relationship Between Medicare Part D Payments to Local, Community Pharmacies and the Pharmacies' Drug Acquisition Costs."
Making a concerted effort to increase positive emotion shows promise as a way to improve wellness and address burnout in nurses, according to an article in AACN Advanced Critical Care.
Researchers of the hereditary cancer research group at the Bellvitge Biomedical Research Institute and the Catalan Institute of Oncology conducted a functional and structural study of seven missense variants of the BRCA1 gene concluding that three of these variants are pathogenic, linked to the risk of suffering breast or ovarian cancer.
› Verified 7 days ago
| NPI Number | 1588610505 |
| Organization Name | ALBERTSONS LLC |
| Doing Business As | SAV-ON PHARMACY #0469 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 12811 Beverly Park Rd, Lynnwood, WA 98087 |
| Phone Number | 425-347-3145 |
News Archive
AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.
The Office of the Inspector General of the Department of Health and Human Services released a "Review of the Relationship Between Medicare Part D Payments to Local, Community Pharmacies and the Pharmacies' Drug Acquisition Costs."
Making a concerted effort to increase positive emotion shows promise as a way to improve wellness and address burnout in nurses, according to an article in AACN Advanced Critical Care.
Researchers of the hereditary cancer research group at the Bellvitge Biomedical Research Institute and the Catalan Institute of Oncology conducted a functional and structural study of seven missense variants of the BRCA1 gene concluding that three of these variants are pathogenic, linked to the risk of suffering breast or ovarian cancer.
› Verified 7 days ago
News Archive
AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.
The Office of the Inspector General of the Department of Health and Human Services released a "Review of the Relationship Between Medicare Part D Payments to Local, Community Pharmacies and the Pharmacies' Drug Acquisition Costs."
Making a concerted effort to increase positive emotion shows promise as a way to improve wellness and address burnout in nurses, according to an article in AACN Advanced Critical Care.
Researchers of the hereditary cancer research group at the Bellvitge Biomedical Research Institute and the Catalan Institute of Oncology conducted a functional and structural study of seven missense variants of the BRCA1 gene concluding that three of these variants are pathogenic, linked to the risk of suffering breast or ovarian cancer.
› Verified 7 days ago
Safeway Pharmacy #0485 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 19500 Highway 99, Lynnwood, Washington 98036 Phone: (425) 670-9723 | |
Sav-on Pharmacy #0469 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 12811 Beverly Park Rd, Lynnwood, Washington 98087 Phone: (425) 347-3145 | |
Bethel Pharmacy Inc Type: Community/Retail Pharmacy Location: 17414 Highway 99, Lynnwood, Washington 98037 Phone: (425) 740-0075 | |
Pacific Pulmonary Services Type: DME Supplier - Oxygen Equipment & Supplies Location: 18905 33rd Ave W, Lynnwood, Washington 98036 Phone: (425) 620-1410 | |
Fred Meyer #688 Type: Community/Retail Pharmacy Location: 2902 164th St Sw, Lynnwood, Washington 98087 Phone: (425) 787-4933 |